EARLY PRO-2 SYMPTOM REMISSION FOLLOWING GUSELKUMAB INDUCTION TREATMENT: RESULTS THROUGH WEEK 12 OF THE PHASE 2 GALAXI 1 STUDY

Walter Reinisch  1     Tadakazu Hisamatsu  2     Kathleen Weisel  3     Susana Gonzalez  3     Mary Ellen Frustaci  3     Zijiang Yang  3     Jewel Johanns  3     Matthew Germinaro  3     Chenglong Han  4     Jane Andrews  5     Aniita Afzali  6     William Sandborn  7     Brian G. Feagan  8     Omoniyi J. Adedokun  3    
1 Medical University of Vienna, Vienna, Austria
2 Kyorin University, Tokyo, Japan
3 Janssen Research & Development, LLC, Spring House, United States
4 Janssen Global Services, LLC, Malvern, United States
5 Royal Adelaide Hospital & University of Adelaide, Adelaide, Australia
6 The Ohio State University Wexner Medical Center, Columbus, United States
7 University of California San Diego, San Diego, United States
8 Robarts Clinical Trials, Western University, London, Canada

Session
IBD (Posters)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing